Rethinking Cholera and Typhoid Vaccination Policies for the Poor: Private Demand in Kolkata, India

World Development

Volumn 37, Issue 2, 2009, Pages 399-409

  Whittington, Dale ^a,b   Sur, Dipika ^c   Cook, Joseph ^d   Chatterjee, Susmita ^c   Maskery, Brian ^a   Lahiri, Malay ^c   Poulos, Christine ^e   Boral, Srabani ^c   Nyamete, Andrew ^f   Deen, Jacqueline ^f   Ochiai, Leon ^f   Bhattacharya, Sujit Kumar ^c  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c NATIONAL INSTITUTE OF CHOLERA AND ENTERIC DISEASES   (India)

^d UNIVERSITY OF WASHINGTON   (United States)

^e RTI INTERNATIONAL   (United States)

^f International Vaccine Institute   (South Korea)

Author keywords

cholera; India; Kolkata; typhoid; vaccine demand; willingness to pay

Indexed keywords

CHOLERA; CONTINGENT VALUATION; HEALTH IMPACT; HEALTH POLICY; HEALTH RISK; IMMUNIZATION; POVERTY; SOCIOECONOMIC STATUS; TYPHOID; VACCINATION; WILLINGNESS TO PAY;

ASIA; CALCUTTA; EURASIA; INDIA; SOUTH ASIA; WEST BENGAL;

EID: 58149218276     PISSN: 0305750X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.worlddev.2008.04.002     Document Type: Article

References (37)

1. Acosta C., Galindo C., Deen J., Ochiai R., Lee H., von Seidlein, et al. Vaccines against cholera, typhoid fever, and shigellosis for developing countries. Expert Opinion on Biological Therapy 12 (2004) 1939-1951
2. Arrow K., Solow R., Portney P.R., Learner E.E., and Radner R. Report of the NOAA panel on contingent valuation. Federal Register 58 10 (1993) 4601-4614
3. Bayoumi A. The measurement of contingent valuation for health economics: Current opinion. Pharmacoeconomics 22 11 (2004) 691-700
4. Bennett R., and Tranter R. The dilemma concerning choice of contingent valuation willingness to pay elicitation format. Journal of Environmental Planning and Management 41 2 (1998) 253-258
5. Canh D.G., Whittington D., Thoa L.T.K., Utomo N., Hoa N.T., Poulos C., et al. Household demand for typhoid fever vaccines in Hue City, Vietnam: Implications for immunization programs. Health Policy and Planning 21 (2006) 241-255
6. Carson R. Contingent valuation: A user's guide. Environmental Science and Technology 34 (2000) 1413-1418
7. Carson R.T., Flores N.E., Martin K.M., and Wright J.L. Contingent valuation and revealed preference methodologies: Comparing the estimates for quasi-public goods. Land Economics 72 1 (1996) 80-99
8. Carson R.T., Flores N., and Meade N.F. Contingent valuation: Controversies and evidence. Environmental and Resource Economics 19 (2001) 173-210
9. Carson R.T., and Mitchell R.C. The issue of scope in contingent valuation studies. American Journal of Agricultural Economics 75 (1993) 1263-1267
10. Cook, J., Jeuland, M., Maskery, B., Lauria, D., Sur, D., Clemens, J., et al. (in press). Using private demand studies to calculate socially-optimal vaccine subsidies in developing countries. Journal of Policy Analysis and Management.
11. Cook, J., Jeuland, M., Whittington, D., Poulos, C., Clemens, J., Sur, D., et al. (2008). The cost-effectiveness of typhoid Vi vaccination programs: Calculations for four urban sites in four Asian countries (Evans School Working Paper). Seattle, Washington, USA.
12. Cook, J., Sur, D., Clemens, J., & Whittington, D. (2008). Evaluating investments in typhoid vaccines in two Kolkata slums. (Evans School Working Paper). Seattle, Washington, USA.
13. Cook J., Whittington D., Canh D.G., Johnson F.R., and Nyamete A. Reliability of stated preferences for cholera and typhoid vaccines with time to think in Hue, Vietnam. Economic Inquiry 45 1 (2007) 100-114
14. Cropper M.L., Haile M., Lampietti J., Poulos C., and Whittington D. The demand for a malaria vaccine: Evidence from Ethiopia. Journal of Development Economics 75 (2004) 303-318
15. Crump J.A., Luby S.P., and Mintz E.D. The global burden of typhoid fever. Bulletin of the World Health Organization 82 5 (2004) 346-353
16. Cummings R., and Taylor L. Unbiased value estimates for environmental goods: A cheap talk design for the contingent valuation method. American Economic Review 89 3 (1999) 649-665
17. Deen J.L., von Seidlein L., Sur D., Agtini M., Lucas M.E.S., Lopez, et al. The high burden of cholera in children: Comparison of incidence from endemic areas in Asia and Africa. PLoS Neglected Tropical Diseases 2 2 (2008) e173
18. Guh S., Xingbao C., Qu Z., Jianwen C., von Seidlein L., Jichao C., et al. Comparison of cost-of-illness with willingness-to-pay estimates to avoid shigellosis: Evidence from China. Health Policy and Planning 23 2 (2008) 1-12
19. Haab T., and McConnell K. Valuing environmental and natural resources: The econometrics of non-market valuation (2002), Edward Elgar, Cheltenham (UK)
20. Hanemann W.M. Valuing the environment through contingent valuation. Journal of Economic Perspectives 8 4 (1994) 19-43
21. Harrison G.W. Experimental evidence on alternative environmental valuation methods. Environmental and Resource Economics 34 (2006) 125-162
22. Hofler R.A., and List J.A. Valuation on the frontier: Calibrating actual and hypothetical statements of value. American Journal of Agricultural Economics 86 1 (2004) 213-221
23. Indian Ministry of Health and Family Welfare. National Health Accounts 2001-2002. New Delhi. .
24. Islam Z., Maskery B., Nyamete A., Horowitz M., Yunus M., and Whittington D. Private demand for cholera vaccines in rural Bangladesh. Health Policy 85 2 (2008) 184-195
25. In: Jamison D.T., Breman J.G., Measham A.R., Alleyne G., Claesen R., and Evans D.B. (Eds). Disease control priorities in developing countries (2006), The World Bank and Oxford University Press, Washington, DC
26. Jeuland, M., Cook, J., Poulos, C., Lucas, M., Clemens, J., Whittington, D., et al. (2008). Cost effectiveness of new-generation oral cholera vaccines: A multi-country analysis. Unpublished manuscript.
27. Kim D., Canh D.G., Poulos C., Thoa L.T.K., Cook J., Hoa N.T., et al. Private household demand for cholera vaccines in Hue, Vietnam. Value in Health 11 1 (2008) 119-128
28. Kristrom B. A nonparametric approach to the estimation of welfare measures in discrete response valuation studies. Land Economics 66 2 (1990) 135-139
29. Lauria D.T., Whittington D., Choe K., Turingan C., and Abiad V. Household demand for improved sanitation services: A case study of Calamba, Philippines. In: Willis K., and Bateman I. (Eds). Valuing Environmental preferences: Theory and practice of the contingent valuation method (1999), Oxford University Press, Oxford 540-584
30. Lucas M., Jeuland M., Deen J., Lazaro N., MacMahon M., Nyamete, et al. Private demand for cholera vaccines in Beira, Mozambique. Vaccine 25 (2007) 2599-2609
31. O'Brien B.O., and Gafni A. When do the "dollars" make sense? Toward a conceptual framework for contingent valuation studies in health care. Medical Decision Making 16 3 (1996) 288-299
32. Ochiai R.L., Acosta C.J., Danovaro-Holliday M.C., Dong B., Bhattacharya S.K., Agtini, et al. A study of typhoid fever in 5 Asian countries: Disease burden and implications for control. Bulletin of the World Health Organization 86 (2008) 260-268
33. Suraratdecha C., Ainsworth M., Tangcharoensathien V., and Whittington D. The private demand for an AIDS vaccine in Thailand. Health Policy 71 (2005) 271-287
34. Vossler C., and McKee M. Induced-value tests of contingent valuation elicitation mechanisms. Environmental and Resource Economics 35 (2006) 137-168
35. Whittington D., Matsui O., Freiberger J., Van Houtven J., and Pattanayak S. Private demand for an HIV/AIDS vaccine: Evidence from Guadalajara, Mexico. Vaccine 20 (2002) 2585-2591
36. Whittington D., Smith V.K., Okorafor A., Okore A., Liu J.L., and McPhail A. Giving respondents time to think in contingent valuation studies: A developing country application. Journal of Environmental Economics and Management 22 (1992) 205-225
37. World Health Organization (2006). Cholera 2005. Weekly Epidemiological Record 81, 297-308.